The latest health and social care news and a look at research and development into the treatment of common and rare diseases alike. We also look at the vital changes being made to help deliver effective healthcare through the digital transformation within the NHS.
Adam Mence from L&R Medical UK explains how the company is empowering patients to manage their conditions while supporting NHS goals for improving care outcomes and efficiency. Overall, investing in self-care and innovative technologies is shown to be both clinically effective and cost-efficient.
Transcending morphology, magnetic resonance techniques can be utilised to shed light on processes on the molecular level to unveil pathological alterations preceding anatomical and functional manifestations of (cardiovascular) diseases, in the view of Ulrich Flögel from Heinrich Heine University Düsseldorf, Germany.
Dr Richard Angell and Dr Jane Kinghorn from the Drug Discovery Group (Translational Research Office), at University College London (UCL), explain the value of drug discovery in academia in bridging the “Valley of Death”.
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group explores the emerging role of tumour necrosis factor receptor-associated factor 6 including the challenges and opportunities in this vein.
BioBloom has specialised in the production of high-quality organic hemp products with absolutely no additives since 2016. The production focuses on the preservation of all valuable ingredients of the hemp plant.
Of the digitisation projects ongoing at St Helens and Knowsley Teaching Hospitals (STHK) NHS Trust, electronic prescribing and medicines administration (EPMA) represents the biggest step forward for patient safety.
Paola Testori Coggi, Former Director General for Health and Consumers, European Commission speaks to Open Access Government about her work here on defending investments in public health.
SSPC, the Science Foundation Ireland Research Centre for Pharmaceuticals, explains how they are recognised internationally as a hub of process innovation and advanced manufacturing for the pharmaceutical sector.
The NHS reports that 1 in 5 women in the UK are currently affected by PCOS, but what do we really know about the condition? It’s imperative that women have a clear understanding of their reproductive health. here, we explain everything you need to know about PCOS.
In this article, Adrian Brown, Executive Director at the Centre for Public Impact, looks into how the UK can learn from the Netherlands to fix adult social care.
Versus Arthritis underline the importance of forward planning for improved preventive care for people with arthritis and other musculoskeletal conditions.
Here, several experts from the International Society for Biological and Environmental Repositories provide a novel perspective around distributive biobanking models, including why biospecimens need blockchain.
Redefining efficiency based on what matters to cancer patients is placed under the spotlight here by All.Can, including identifying opportunities for change.
